Hot Biotech Market Neglects Stem Cell Therapies, Says CIRM's Neil Littman episode artwork

EPISODE · Nov 18, 2015 · 23 MIN

Hot Biotech Market Neglects Stem Cell Therapies, Says CIRM's Neil Littman

from Mendelspod Podcast · host Theral Timpson

In 2004, California voters approved Prop 71 to fund the field of stem cell research by setting up the California Institute of Regenerative Medicine, or CIRM, with $3 billion. George W. Bush was in the White House at the time, and since 2001, his administration had been limiting research that used embryonic stem cells. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Episode metadata supplied by the publisher feed · Published Nov 18, 2015

Embed this episode

NOW PLAYING

Hot Biotech Market Neglects Stem Cell Therapies, Says CIRM's Neil Littman

0:00 23:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mendelspod Podcast?

This episode is 23 minutes long.

When was this Mendelspod Podcast episode published?

This episode was published on November 18, 2015.

Can I download this Mendelspod Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!